Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
37.6M
-
Shares change
-
+4.11M
-
Total reported value, excl. options
-
$1.38B
-
Value change
-
+$160M
-
Put/Call ratio
-
0.39
-
Number of buys
-
84
-
Number of sells
-
-56
-
Price
-
$36.60
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q3 2020
170 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.6M shares
of 69.1M outstanding shares and own 54.4% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (2.88M shares), WELLINGTON MANAGEMENT GROUP LLP (2.7M shares), VANGUARD GROUP INC (2.62M shares), BlackRock Inc. (2.22M shares), Clearbridge Investments, LLC (1.65M shares), ALLIANCEBERNSTEIN L.P. (1.61M shares), Capital International Investors (1.34M shares), JANUS HENDERSON GROUP PLC (1.25M shares), VICTORY CAPITAL MANAGEMENT INC (1.19M shares), and FMR LLC (1.08M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.